Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2008-08-13 11:22:33 UTC |
---|
Update Date | 2022-03-07 02:49:33 UTC |
---|
HMDB ID | HMDB0006841 |
---|
Secondary Accession Numbers | - HMDB0006541
- HMDB0059618
- HMDB06541
- HMDB06841
- HMDB59618
|
---|
Metabolite Identification |
---|
Common Name | 5alpha-Cholest-8-en-3beta-ol |
---|
Description | 5alpha-Cholest-8-en-3beta-ol, also known as zymostenol, is a normal human metabolite and an intermediate of cholesterol synthesis. The concentrations of zymostenol are higher, both in the serum and bile of patients with cerebrotendinous xanthomatosis, compared to controls or in patients with cerebrotendinous xanthomatosis treated with chenodeoxycholic acid. Kidney transplant recipients had lower serum zymostenol when compared to controls. During consumption of plant stanol ester spread by hypercholesterolemic children, plant sterols in the plasma decreased and cholesterol precursor sterols such as zymostenol increased (PMID: 15736111 , 16709621 , 16477216 , 12756385 ). |
---|
Structure | [H][C@@]1(CC[C@@]2([H])C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C[C@]1([H])CC3)[C@H](C)CCCC(C)C InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cholestenol | ChEBI | Zymostenol | ChEBI | 5a-cholest-8-en-3b-ol | Generator | 5α-cholest-8-en-3β-ol | Generator | (3beta,5alpha)Cholestenol | HMDB | 3beta-Hydroxy-8(9)-cholestene | HMDB | 3beta-Hydroxycholest-8(9)-ene | HMDB | 5-alpha-Cholest-8-en-3-beta-ol | HMDB | 5alpha-Cholest-8(9)-en-3beta-ol | HMDB | 5alpha-Cholest-8-en-3beta-ol | HMDB | Cholest-8(9)-en-3beta-ol | HMDB | Cholesta-8(9)-en-3beta-ol | HMDB | delta(8)-Cholestenol | HMDB | 8(9)-Cholestenol | HMDB | Zymostenol, (3beta)-isomer | HMDB | (3beta,5alpha)-Cholest-8-en-3-ol | HMDB | (3Β,5α)-cholest-8-en-3-ol | HMDB | 3beta-Hydroxy-5alpha-cholest-8(9)-ene | HMDB | 3Β-hydroxy-5α-cholest-8(9)-ene | HMDB | 5a-Cholest-8-en-3b-ol | HMDB | 5Α-cholest-8-en-3β-ol | HMDB | Dihydrozymosterol | HMDB | delta8-Cholestenol | HMDB | Δ8-cholestenol | HMDB |
|
---|
Chemical Formula | C27H46O |
---|
Average Molecular Weight | 386.6535 |
---|
Monoisotopic Molecular Weight | 386.354866094 |
---|
IUPAC Name | (2S,5S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-5-ol |
---|
Traditional Name | (2S,5S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-5-ol |
---|
CAS Registry Number | 566-97-2 |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C[C@]1([H])CC3)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1 |
---|
InChI Key | QETLKNDKQOXZRP-XTGBIJOFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Cholestane steroids |
---|
Direct Parent | Cholesterols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Cholesterol-skeleton
- 3-beta-hydroxysteroid
- Hydroxysteroid
- 3-hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.59 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 27.1197 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.71 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3466.6 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 843.2 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 324.0 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 343.3 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 653.2 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1231.4 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1115.7 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 107.2 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2166.0 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 686.5 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2286.6 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 790.9 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 599.1 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 351.4 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 761.2 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 5alpha-Cholest-8-en-3beta-ol GC-MS (Non-derivatized) - 70eV, Positive | splash10-076r-1019000000-da210f056bd723d532a1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5alpha-Cholest-8-en-3beta-ol GC-MS (1 TMS) - 70eV, Positive | splash10-0006-3105900000-25f7266fb84218fbea74 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5alpha-Cholest-8-en-3beta-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 10V, Positive-QTOF | splash10-014r-0009000000-a776f0a6c0141e92ae73 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 20V, Positive-QTOF | splash10-05p9-3139000000-e84343d3954ffbe258f2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 40V, Positive-QTOF | splash10-0a4i-5249000000-5b6b7a2f03b59d093325 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 10V, Negative-QTOF | splash10-000i-0009000000-315c5133aa81b3939474 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 20V, Negative-QTOF | splash10-000i-0009000000-711bf432a79ce66b987f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 40V, Negative-QTOF | splash10-0ldi-1019000000-b4dfc241017aaa46ed22 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 10V, Negative-QTOF | splash10-000i-0009000000-c037f2d2f217e99b79ac | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 20V, Negative-QTOF | splash10-000i-0009000000-c037f2d2f217e99b79ac | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 40V, Negative-QTOF | splash10-001i-0009000000-04cb77df44ddc15c479c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 10V, Positive-QTOF | splash10-00kr-0009000000-41e086d5b3ca90d0da91 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 20V, Positive-QTOF | splash10-0609-9345000000-80072d6556dbb8a419e1 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5alpha-Cholest-8-en-3beta-ol 40V, Positive-QTOF | splash10-0ab9-8950000000-c4785344c8ab4e1aea5c | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Siirtola A, Ketomaki A, Miettinen TA, Gylling H, Lehtimaki T, Holmberg C, Salo MK, Antikainen M: Cholesterol absorption and synthesis in pediatric kidney, liver, and heart transplant recipients. Transplantation. 2006 Feb 15;81(3):327-34. [PubMed:16477216 ]
- Clarenbach JJ, Lindenthal B, Dotti MT, Federico A, Kelleher JK, von Bergmann K: Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis. Metabolism. 2005 Mar;54(3):335-44. [PubMed:15736111 ]
- Oostendorp M, Engelke UF, Willemsen MA, Wevers RA: Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem. 2006 Jul;52(7):1395-405. Epub 2006 May 18. [PubMed:16709621 ]
- Ketomaki AM, Gylling H, Antikainen M, Siimes MA, Miettinen TA: Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. J Pediatr. 2003 May;142(5):524-31. [PubMed:12756385 ]
|
---|